Patent details

Basic Information

Publication number:

EP3551651

PCT Application Number:

EP2017082290

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP178322111

PCT Publication Number:

WO2018104561

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ACYLATED GLP-1/GLP-2 DUAL AGONISTS

French Title of Invention:

DOUBLES AGONISTES GLP-1/GLP-2 ACYLÉS

German Title of Invention:

ACYLIERTE GLP-1/GLP-2 DUALE AGONISTE

SPC Number:

Dates

Filing date:

11/12/2017

Grant date:

06/03/2024

EP Publication Date:

16/10/2019

PCT Publication Date:

14/06/2018

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/03/2024

EP B1 Publication Date:

06/03/2024

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

11/12/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

28/02/2024

 

 

Name:

Zealand Pharma A/S

Address:

Sydmarken 11, 2860 Søborg, Denmark (DK)

Inventor

1

Name:

DUE LARSEN, Bjarne

Address:

Denmark (DK)

2

Name:

GRIFFIN, Jonathan

Address:

Sweden (SE)

3

Name:

GIEHM, Lise

Address:

Denmark (DK)

4

Name:

EDWARDS, Alistair Vincent Gordon

Address:

Denmark (DK)

Priority

Priority Number:

PA201600757

Priority Date:

09/12/2016

Priority Country:

Denmark (DK)

Classification

IPC classification:

C07K 14/605; A61K 38/26;

Publication

European Patent Bulletin

Issue number:

202410

Publication date:

06/03/2024

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

30/06/2025

Annual Fee Number:

8

Annual Fee Amount:

99 Euro

Penalty Fee Amount:

20 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages